{
  "content": "The definition of bradycardia varied among the included trials. The trials RAAFT-2,19 MANTRA-PAF,18 and EARLY- AF21 included patients with bradycardia who required pacemaker implantation. The STOP AF22 trial included patients with bradycardia resulting in a life-threatening injury, hospitalization, or intervention, and the RAAFT17 trial included only patients with documented bradycardia with no other prespecified criteria.\nStatistical Analysis",
  "source": "https://jamanetwork.com/journals/jamacardiology/fullarticle/2779384",
  "chunk_id": "960130b1-8708-42f6-8aba-226a4314d43b",
  "similarity_score": 0.18203330039978027,
  "query": "beta-blockers safety profile atrial fibrillation heart failure contraindications bradycardia hypotension",
  "rank": 48,
  "title": "Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials",
  "authors": "Mohit K. Turagam, Daniel Musikantow, William Whang, Jacob S. Koruth, Marc A. Miller, Marie-Noelle Langan, Aamir Sofi, Subbarao Choudry, Srinivas R. Dukkipati, Vivek Y. Reddy",
  "year": "2021",
  "journal": "JAMA Cardiology",
  "reference": "Turagam, M. K., Musikantow, D., Whang, W., Koruth, J. S., Miller, M. A., Langan, M.-N., Sofi, A., Choudry, S., Dukkipati, S. R., & Reddy, V. Y. (2021). Assessment of catheter ablation or antiarrhythmic drugs for first-line therapy of atrial fibrillation: A meta-analysis of randomized clinical trials. JAMA Cardiology, 6(6), 697â€“705. https://doi.org/10.1001/jamacardio.2021.0852",
  "doi": "10.1001/jamacardio.2021.0852",
  "chunk_index": 34,
  "total_chunks": 108,
  "retrieved_at": "2025-07-24T21:57:55.188806"
}